Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.
A. Gennari, S. Donati, B. Salvadori, A. Giorgetti, P. A. Salvadori, O. Sorace, G. Puccini, P. Pisani, M. Poli, D. Dani, E. Landucci, G. Mariani, P. F. Conte
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.'. Together they form a unique fingerprint.